GSK PLC (GSK)
41.02
+0.12
(+0.28%)
USD |
NYSE |
Apr 26, 10:48
GSK Shareholders Equity (Quarterly): 17.00B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 17.00B |
| September 30, 2023 | 16.02B |
| June 30, 2023 | 16.01B |
| March 31, 2023 | 14.64B |
| December 31, 2022 | 12.83B |
| September 30, 2022 | 10.22B |
| June 30, 2022 | 19.86B |
| March 31, 2022 | 21.26B |
| December 31, 2021 | 20.32B |
| September 30, 2021 | 20.71B |
| June 30, 2021 | 21.28B |
| March 31, 2021 | 20.43B |
| December 31, 2020 | 19.88B |
| September 30, 2020 | 18.38B |
| June 30, 2020 | 16.73B |
| March 31, 2020 | 16.20B |
| December 31, 2019 | 14.95B |
| September 30, 2019 | 14.47B |
| June 30, 2019 | 4.580B |
| March 31, 2019 | 5.235B |
| December 31, 2018 | 4.798B |
| September 30, 2018 | 5.832B |
| June 30, 2018 | 4.810B |
| March 31, 2018 | -96.70M |
| December 31, 2017 | -91.90M |
| Date | Value |
|---|---|
| September 30, 2017 | 1.738B |
| June 30, 2017 | 1.055B |
| March 31, 2017 | 2.139B |
| December 31, 2016 | 1.381B |
| September 30, 2016 | 178.89M |
| June 30, 2016 | 772.70M |
| March 31, 2016 | 4.035B |
| December 31, 2015 | 7.576B |
| September 30, 2015 | 8.230B |
| June 30, 2015 | 10.72B |
| March 31, 2015 | 11.01B |
| December 31, 2014 | 6.635B |
| September 30, 2014 | 8.190B |
| June 30, 2014 | 10.42B |
| March 31, 2014 | 11.01B |
| December 31, 2013 | 11.54B |
| September 30, 2013 | 9.658B |
| June 30, 2013 | 9.781B |
| March 31, 2013 | 10.17B |
| December 31, 2012 | 9.373B |
| September 30, 2012 | 10.10B |
| June 30, 2012 | 10.94B |
| March 31, 2012 | 14.00B |
| December 31, 2011 | 12.38B |
| September 30, 2011 | 11.61B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
4.580B
Minimum
Jun 2019
21.28B
Maximum
Jun 2021
16.62B
Average
16.73B
Median
Jun 2020
Shareholders Equity (Quarterly) Benchmarks
| AstraZeneca PLC | 39.14B |
| Haleon PLC | 21.15B |
| Novo Nordisk A/S | 15.82B |
| Pfizer Inc | 89.01B |
| Sanofi SA | 81.84B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 75.17B |
| Total Liabilities (Quarterly) | 58.87B |
| Debt to Equity Ratio | 1.260 |
| Current Ratio | 0.8849 |
| Net Debt Paydown Yield | 0.87% |